Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1995-05-18
1998-11-24
Minnifield, Nita
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 72, 435 723, 435 71, 435 4, G01N 33567, G01N 33574, G01N 3353, C12Q 100
Patent
active
058405038
ABSTRACT:
Disclosed is a method for evaluating the efficacy of a therapy associated with cell death in a patient undergoing such a therapy. The method involves providing at least two body fluid samples drawn from the patient, wherein a second sample is drawn from the patient after a first sample, and measuring the quantity per unit volume of a body-fluid soluble interior nuclear matrix protein in each of the samples. By comparing the quantity per unit volume of the body fluid-soluble interior nuclear matrix protein in the first sample with the quantity per unit volume of the body fluid-soluble interior nuclear matrix protein in the second sample, it is possible to determine whether there has been an increase or decrease of cell death in the patient during therapy.
REFERENCES:
patent: 4628027 (1986-12-01), Gay
patent: 4806463 (1989-02-01), Goodchild et al.
patent: 4861581 (1989-08-01), Epstein et al.
patent: 4882268 (1989-11-01), Penman et al.
patent: 4885236 (1989-12-01), Penman et al.
patent: 4937185 (1990-06-01), Webb et al.
patent: 5032508 (1991-07-01), Naughton et al.
patent: 5098890 (1992-03-01), Gewtiz et al.
patent: 5273877 (1993-12-01), Fey et al.
patent: 5686562 (1997-11-01), Toukatly et al.
patent: 5698439 (1997-12-01), Toukatly et al.
Getzenberg et al. (1990) "Tissue Specificity and Cell Death are Associated with Specific Alterations in Nuclear Matrix Proteins," Abstract published in The Journal of Urology, AUA Eighty-fifth Annual Meeting, May 13-17, 1990, 143: No. 4, Abstract No. 155.
Miller et al. (1991) "Release of Nuclear Matrix Proteins during Apoptotic Cell Death," Abstract published in J. Cell Biol., 115: No. 3, Abstract No. 1822.
Miller et al. (1992) "Detection of Nuclear Matrix Proteins in Serum from Cancer Patients," Cancer Research, 52:422-427.
Compton et al., "Identification of Novel Centromere/Kinetochore-associated Proteins Using Monoclonal Antibodies Generated Against Human Mitotic Chromosome Scaffolds"; J. of Cell Biol.; 112 (No. 6):1083-1097 (Mar. 1991).
Fey et al., "The Nuclear Matrix: Defining Structural and Functional Roles"; Critical Reviews in Euk. Gene Expression; 1(2):127-143 (1991).
Kallajoki, et al.;"A 210 kD nuclear matrix protein is a functional part of the mitotic spindle; a microinjection study using SPN monoclonal antibodies," EMBO J.; 10:3351-3362 (1991).
Keesee et al., "Utilization of Nuclear Matrix Proteins for Cancer Diagnosis," Critical Reviews in Eukaryotic Gene Expression; 6(2&3):189-214 (1996).
Lydersen et al., "Human-Specific Nuclear Protein That Associates with the Polar Region of the Mitotic Apparatus: Distribution in a Human/Hamster Hybrid Cell," Cell; 22:489-499 (1980).
Maekawa et al., "Identification of a Minus End-Specific Microtubule-Assoicated Protein Located at the Mitotic Poles in Cultured Mammalian Cells," European J. of Cell Biology; 54:255-267 (1991).
Oeller et al., "Reversible Inhibition of Tomato Fruit Senescence by Antisense RNA," Science; 254:437-439 (1991).
Thibodeau et al., "Monoclonal Antibody CC-3 Recognizes Phosphoproteins in Interphase and Mitotic Cells," Experimental Cell Research; 195:145-153 (1991).
Tousson, "Centrophilin: A Novel Mitotic Spindle Protein Involved in Microtubule Nucleation," J. of Cell Biol.; 112 (No. 3):427-440 (1991).
Whitfield et al., "Cloning of a Gene Encoding an Antigen Associated with the Centrosome in Drosophila," J. of Cell Science; 89:467-480 (1988).
News Release, "Clinical Utility of Matritech's Bladder Cancer Test Reported in August Issue of Journal of Urology," (Jul. 1996).
Kohler et al. (1975) "Continuous Culures of Fused Cells Secreting Antibody of Predefined Specificity," Nature 256:495-497.
Wyllie et al. (1980) "Cell Death: The Significance of Apoptosis," International Review of Cytol. 68:251-306.
Scopes, R.K. (1982) Protein-Purification--Principles and Practice Springer-Verlag Eds., New York, pp. 43-52.
Weeks et al. (1986) "Immunoassays Using Acridinium Esters," Methods in Enzymology 133:366-387.
Walker et al. (1988) "Patterns of Cell Death," Meth. Achiev. Exp. Pathol. 13:18-54.
Fey et al. (1988) "Nuclear Matrix Proteins Reflect Cell Type of Origin in Cultured Human Cells," Proc. Natl. Acad. Sci. USA 85:121-125.
Domasheno et al. (1990) "Comparison of the Spectra of Proteins Synthesized in Mouse Thymocytes After Irradiation or Hydrocortisone Treatment," Int. J. Radiol. Biol. 57(2):315-329.
Genetic Eng News, Journal Announcement, Jul.-Aug. 1990, 10(7):28.
Larrick et al. (1990) "Cytotoxic Mechanism of Tumor Necrosis Factor-.alpha.," FASEB J. 4:3215-3223.
Beausang Lee Anne
Lidgard Graham P.
Miller Thomas E.
Matritech, Inc.
Minnifield Nita
LandOfFree
Nuclear matrix protein fluid assay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nuclear matrix protein fluid assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nuclear matrix protein fluid assay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1700616